VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,319 | -43.2% | 575 | -39.0% | 0.01% | -30.8% |
| Q1 2023 | $30,480 | +12.9% | 942 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $27,003 | +17.4% | 942 | +0.4% | 0.01% | +18.2% |
| Q3 2022 | $23,000 | -11.5% | 938 | 0.0% | 0.01% | -8.3% |
| Q2 2022 | $26,000 | -63.9% | 938 | -50.0% | 0.01% | -20.0% |
| Q1 2022 | $72,000 | +227.3% | 1,876 | +175.1% | 0.02% | +50.0% |
| Q4 2021 | $22,000 | +10.0% | 682 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $20,000 | +25.0% | 682 | +47.0% | 0.01% | +25.0% |
| Q2 2021 | $16,000 | +6.7% | 464 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $15,000 | -11.8% | 464 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $17,000 | -50.0% | 464 | -46.4% | 0.01% | -56.0% |
| Q3 2020 | $34,000 | – | 865 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |